Clinical Trials Directory

Trials / Terminated

TerminatedNCT03772821

Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery

Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery: Prospective Multicenter Cohort Study

Status
Terminated
Phase
Study type
Observational
Enrollment
163 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

No prospective study has yet evaluated the factors influencing the complications of femoral bifurcation surgery in France. Daily practice of investigators suggests that conventional surgical treatment has had a higher rate of local complications in recent years for a variety of reasons that remain to be assessed (aging, overweight, chronic renal failure, diabetes, or other), but as of yet, investigators do not have proof of such an effect. The proposed study would follow a prospective, continuous, multicentre cohort of patients to describe the type, frequency and factors that contribute to local and general complications of surgery on the femoral bifurcation. This information is essential in the choice of the best revascularization technique for the femoral artery, which is frequently the site used for interventions in vascular conditions. Surgeries will be performed in the normal manner. The research will be based on medical data collected during patient management. A measurement of the incision/scar will be taken once the procedure has been performed, either immediately after surgery or after a period of time, during post-operative consultation. Participation in this research will last 3 months from the day of the intervention.

Conditions

Interventions

TypeNameDescription
OTHERData collectionBetween D0 and D90: local and general complications, demographic, clinical, paraclinical and biological data
OTHERIncision/scar measurementBetween D0 and D90

Timeline

Start date
2019-01-08
Primary completion
2020-03-02
Completion
2020-03-02
First posted
2018-12-11
Last updated
2024-07-01

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03772821. Inclusion in this directory is not an endorsement.